Moderate to severe Crohn’s Disease

Location: Long Beach

Stay: None

Gender: Male/Female

Ages: 18-80

Compensation: $60 per visit

Smokers Allowed: Yes

Study Overview:

To evaluate the efficacy of MEDI2070 versus placebo to induce clinical remission based on the CDAI score in subjects with moderate to severe Crohn's Disease who have failed or are intolerant to anti-TNFα therapy.

Enroll In This Study